Original Research

Published on 21 Sep 2023

Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study

Sabine Dettmer
Oliver Weinheimer
Annette Sauer-Heilborn
Oliver Lammers
Mark O. Wielpütz
Jan Fuge
Tobias Welte
Frank Wacker
Felix C. Ringshausen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1245885

116 views

Original Research

Accepted on 18 Sep 2023

EXPOSURE-RESPONSE ANALYSES OF EFZOFITIMOD IN PATIENTS WITH PULMONARY SARCOIDOSIS

Gennyne Walker
Ryan Adams
Lauren Guy
Abhijeeth Chandrasekaran
Nelson Kinnersley
Pavithra Ramesh
Lu Zhang
Fran Brown
Vis Niranjan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258236

Original Research

Published on 14 Sep 2023

Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation

Yan Feng
Han Qiao
Hongyun Liu
Jvfei Wang
Huaping Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218030

267 views

Original Research

Accepted on 13 Sep 2023

Hypoxia releases S-nitrosocysteine from carotid body glomus cells -relevance to expression of the hypoxic ventilatory response

Stephen John Lewis
James Seckler
Paulina Getsy
Walter May
Benjamin Gaston
Santhosh M Baby
Tristan Lewis
James N Bates

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1250154

Original Research

Published on 05 Sep 2023

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension

Patrick A. Link
Laszlo Farkas
Rebecca L. Heise

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192798

626 views

Original Research

Published on 01 Sep 2023

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

Rupeng Shi
Yuanyuan Fu
Yujing Gan
Danying Wu
Suming Zhou
Min Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222044

372 views

Original Research

Published on 24 Aug 2023

Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

Yunduan Song
Yusen Gou
Jiameng Gao
Dongxin Chen
Haibo Zhang
Wenjuan Zhao
Feng Qian
Ajing Xu
Yao Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236469

628 views

Original Research

Published on 23 Aug 2023

Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway

Ravishankar Chandrasekaran
Carolyn R. Morris
Isabella M. Butzirus
Zoe F. Mark
Amit Kumar
Dhemerson Souza De Lima
Nirav Daphtary
Minara Aliyeva
Matthew E. Poynter
Vikas Anathy

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1248873

575 views

Original Research

Published on 16 Aug 2023

A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release

Götz Schmidt
Gerrit Rienas
Sabrina Müller
Fabian Edinger
Michael Sander
Christian Koch
Michael Henrich

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155930

562 views

Original Research

Published on 16 Aug 2023

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study

Zhenping Wu
Siying Zhang
Yelin Cao
Qiyu Wang
Keyuan Sun
Xia Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209063

387 views

Original Research

Published on 16 Aug 2023

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis

Ling Sun
Ya-Fei Chang
Yun-Fei Wang
Xian-Zhong Ran
Xiang-Rong Li
Quan-Xin Xie
Bin Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123945

441 views

Editorial

Published on 15 Aug 2023

Editorial: Case reports in respiratory pharmacology 2022

Przemyslaw Zdziarski
Luisa Ricciardi
Roberto Paganelli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242273

430 views

Review

Published on 07 Aug 2023

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

Hehua Guo
Jiazheng Sun
Siyu Zhang
Yalan Nie
Sirui Zhou
Yulan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205948

1,309 views

Review

Published on 03 Aug 2023

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

Peng Pi
Zhipeng Zeng
Liqing Zeng
Bing Han
Xizhe Bai
Shousheng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218059

854 views

Clinical Trial

Published on 28 Jul 2023

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial

Xiaobo Yang
Yun Tang
Ruofei Du
Yuan Yu
Jiqian Xu
Jiancheng Zhang
Hong Liu
Xiaojing Zou
Lehao Ren
Shiying Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139872

662 views

Correction

Published on 26 Jul 2023

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

Wenjiang Zheng
Ting Wang
Peng Wu
Qian Yan
Chengxin Liu
Hui Wu
Shaofeng Zhan
Xiaohong Liu
Yong Jiang
Hongfa Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256022

600 views

Navigation group

Articles

Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study

EXPOSURE-RESPONSE ANALYSES OF EFZOFITIMOD IN PATIENTS WITH PULMONARY SARCOIDOSIS

Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation

Hypoxia releases S-nitrosocysteine from carotid body glomus cells -relevance to expression of the hypoxic ventilatory response

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway

A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis

Editorial: Case reports in respiratory pharmacology 2022

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19